New combo attack on lung cancer brain tumors
NCT ID NCT02696993
Summary
This study is testing whether combining immunotherapy drugs with targeted radiation to the brain works better to control advanced lung cancer that has spread there. It aims to find the safest and most effective doses of the drugs nivolumab and ipilimumab when given with two different types of brain radiation. The trial will also measure how long the treatment keeps the brain tumors from growing and monitor side effects, including potential impacts on memory and thinking.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MALIGNANT NEOPLASM IN THE BRAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.